Key facts
- This page summarizes Nir Naor's Form 4 filing for Axogen, Inc. (AXGN).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 06 Jan 2025, 18:39.
Nir Naor - 06 Jan 2025 Form 4 Insider Report for Axogen, Inc. (AXGN)
- Reporting relationship
- CFO
- Issuer ticker
- AXGN
- Reported as of
- 06 Jan 2025
- Net transaction value
- -$595,589
- SEC form
- 4
- Accepted by SEC
- 06 Jan 2025, 18:39:06 UTC
- Prior SEC filing
- 03 Jan 2025
- Next SEC filing
- 20 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Nir Naor
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Nir Naor filed Form 4 for Axogen, Inc. (AXGN) on 06 Jan 2025.
Change
- Previous filing in this sequence was filed on 03 Jan 2025.
- Current net transaction value: -$595,589.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AXGN
transaction
Common Stock
Tax liability
- Transaction value
- $595,589
- Shares
- -39,132
- Change %
- -13%
- Price
- $15.22
- Shares after
- 260,868
- Date
- 06 Jan 2025
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units.
Footnote F2
The reported price in Column 4 is a weighted average sale price. These shares were sold on January 6, 2025 in multiple transactions at prices ranging from $14.37 to $15.26 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.